(Q40957620)

25 September 2017

1 reference

title

Host defences in continuous ambulatory peritoneal dialysis and the genesis of peritonitis (English)

1 reference

25 September 2017

0 references

1 reference

J S Cameron

1

1 reference

25 September 2017

language of work or name

1 reference

1 October 1995

1 reference

25 September 2017

1 reference

25 September 2017

volume

9

1 reference

25 September 2017

issue

5

1 reference

25 September 2017

page(s)

647-662

1 reference

A five-year study of the microbiologic results of exit site infections and peritonitis in continuous ambulatory peritoneal dialysis

25 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF00860966

A review of Staphylococcus aureus exit-site and tunnel infections in peritoneal dialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00860966

Exit-site and tunnel infections in continuous ambulatory peritoneal dialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00860966

Neutrophil and monocyte alterations in chronic dialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00860966

Specific opsonic activity for staphylococci in peritoneal dialysis effluent during continuous ambulatory peritoneal dialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00860966

Effect of vancomycin hydrochloride on Staphylococcus epidermidis biofilm associated with silicone elastomer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00860966

Analysis of peritoneal macrophages in continuous ambulatory peritoneal dialysis patients

21 January 2018

1 reference

12 December 2020

Host defence in CAPD treatment: the effect of the dialysate on cell function.

1 reference

12 December 2020

Fibronectin during CAPD-related peritonitis: no indications for intraperitoneal production

1 reference

12 December 2020

Toxicity of osmotic solutes on human mesothelial cells in vitro

1 reference

12 December 2020

Peritonitis with continuous ambulatory peritoneal dialysis and continuous cycling peritoneal dialysis

1 reference

12 December 2020

Exit-site infection during continuous and cycling peritoneal dialysis in children

1 reference

12 December 2020

Infecting organisms in continuous ambulatory peritoneal dialysis patients on the Y-set

1 reference

12 December 2020

Laboratory and clinical evaluation of conjugate vaccines composed of Staphylococcus aureus type 5 and type 8 capsular polysaccharides bound to Pseudomonas aeruginosa recombinant exoprotein A

1 reference

12 December 2020

Opsonic deficiency of peritoneal dialysis effluent in continuous ambulatory peritoneal dialysis

1 reference

12 December 2020

Adherence of Staphylococcus aureus to cultures of human peritoneal mesothelial cells

1 reference

12 December 2020

Cell populations present in the nocturnal peritoneal effluent of patients on continuous ambulatory peritoneal dialysis and their relationship with peritoneal function and incidence of peritonitis

1 reference

12 December 2020

Biofilm and peritonitis in peritoneal dialysis

1 reference

12 December 2020

Nutritional regulation of immunity and risk of infection in old age.

1 reference

12 December 2020

Five years' experience with continuous ambulatory or continuous cycling peritoneal dialysis in children

1 reference

12 December 2020

Leukocytes in peritoneal dialysis effluents. Danish Study Group on Peritonitis in Dialysis (DASPID).

1 reference

12 December 2020

Interferon-gamma (IFN-gamma) as in vitro enhancing factor of peritoneal macrophage defective bactericidal activity during continuous ambulatory peritoneal dialysis (CAPD)

1 reference

12 December 2020

Strain differences in the opsonisation of Staphylococcus epidermidis

1 reference

12 December 2020

Continuous ambulatory peritoneal dialysis and survival of HIV infected patients with end-stage renal disease

1 reference

12 December 2020

Opsonic activity of dialysis effluent predicts those at risk of Staphylococcus epidermidis peritonitis

1 reference

12 December 2020

Peritoneal dialysis induces a local sterile inflammatory state and the mesothelial cells in the effluent are related to the bacterial peritonitis incidence

1 reference

12 December 2020

Treatment of resistant peritonitis in continuous ambulatory peritoneal dialysis with intraperitoneal urokinase: a double-blind clinical trial.

1 reference

12 December 2020

Mechanisms of polymorphonuclear leukocyte mediated peritoneal mesothelial cell injury

1 reference

12 December 2020

Human resident peritoneal macrophages: phenotype and biology.

1 reference

12 December 2020

Prevention of peritonitis in continuous ambulatory peritoneal dialysis

1 reference

12 December 2020

Bactericidal activity of peritoneal macrophages from continuous ambulatory dialysis patients

1 reference

12 December 2020

Antigen-presenting capacity of macrophages and dendritic cells in the peritoneal cavity of patients treated with peritoneal dialysis

1 reference

12 December 2020

Longitudinal study of peritoneal defence mechanisms in patients on continuous ambulatory peritoneal dialysis (CAPD).

1 reference

12 December 2020

Serial peritoneal macrophage function studies in new and established continuous ambulatory peritoneal dialysis patients

1 reference

12 December 2020

Activation of immunocompetent cells in the peritoneum of patients treated with CAPD.

1 reference

12 December 2020

Clinical applications of crossed immunoelectrophoresis to the study of complement activation.

1 reference

12 December 2020

Fibronectin and complement secretion by monocytes and peritoneal macrophages in vitro from patients undergoing continuous ambulatory peritoneal dialysis

1 reference

12 December 2020

The mesothelial cells in CAPD effluent and their relation to peritonitis incidence.

1 reference

12 December 2020

Immunological defenses in CAPD.

1 reference

12 December 2020

Role of mesothelial cells in peritoneal antibacterial defence

1 reference

12 December 2020

Peritoneal dialysis fluid inhibition of polymorphonuclear leukocyte respiratory burst activation is related to the lowering of intracellular pH

1 reference

12 December 2020

Risk factors for peritonitis and technique failure in CAPD: increased age and dialysate IgG protect against peritonitis

1 reference

12 December 2020

Peritonitis in childhood renal disease

1 reference

12 December 2020

Flow cytometric study of immunocompetent cell phenotypes and phagocytosis in CAPD effluent

1 reference

12 December 2020

Long-term effects of peritoneal dialysis on peritoneal morphology

1 reference

12 December 2020

Peritonitis during continuous ambulatory peritoneal dialysis in children

1 reference

12 December 2020

Peritoneal fibrinolytic activity and intra-abdominal adhesions

1 reference

12 December 2020

The washout kinetics of intraperitoneal IgG in CAPD patients

1 reference

12 December 2020

In-vitro biocompatibility of alternative CAPD fluids; comparison of bicarbonate-buffered and glucose-polymer-based solutions.

1 reference

12 December 2020

The polymorph neutrophil in CAPD patients

1 reference

12 December 2020

Continuous peritoneal dialysis for children: a decade of worldwide growth and development.

1 reference

12 December 2020

Immuno-effector characteristics of peritoneal cells during CAPD treatment: a longitudinal study.

1 reference

12 December 2020

Stimulation of peritoneal synthesis of vasoactive prostaglandins during peritonitis in patients on continuous ambulatory peritoneal dialysis

1 reference

12 December 2020

Surface phagocytosis and host defence in the peritoneal cavity during continuous ambulatory peritoneal dialysis

1 reference

12 December 2020

Isolation, culture and characterization of human peritoneal mesothelial cells

1 reference

12 December 2020

Effect of lactate-buffered peritoneal dialysis fluids on human peritoneal mesothelial cell interleukin-6 and prostaglandin synthesis

1 reference

12 December 2020

Peritoneal immune defense in continuous ambulatory peritoneal dialysis: clinical relevance and practical implications

1 reference

12 December 2020

Removal and replacement of Tenckhoff catheter at a single operation: successful treatment of resistant peritonitis in continuous ambulatory peritoneal dialysis.

1 reference

12 December 2020

Peritonitis in children undergoing continuous ambulatory peritoneal dialysis

1 reference

12 December 2020

Host defense mechanisms in continuous ambulatory peritoneal dialysis

1 reference

12 December 2020

Comparison of peritoneal white blood cell parameters from continuous ambulatory peritoneal dialysis patients with a high or low incidence of peritonitis

1 reference

12 December 2020

Only simultaneous blocking of the L- and P-selectin completely inhibits neutrophil migration into mouse peritoneum

1 reference

12 December 2020

Peritoneal defense in continuous ambulatory versus continuous cyclic peritoneal dialysis

1 reference

12 December 2020

Peritoneal dialysis fluid biocompatibility: does it really matter?

1 reference

12 December 2020

Gene expression and release of interleukin-8 by peritoneal macrophages and polymorphonuclear leukocytes during peritonitis in uremic patients on continuous ambulatory peritoneal dialysis

1 reference

12 December 2020

Preventing Staphylococcus aureus infection during chronic peritoneal dialysis

1 reference

12 December 2020

Risk of peritonitis and technique failure by CAPD connection technique: a national study

1 reference

12 December 2020

Host defence in continuous ambulatory peritoneal dialysis: the effect of the dialysate on phagocyte function

1 reference

12 December 2020

Peritonitis prevention in CAPD by intraperitoneal IgG

1 reference

12 December 2020

Appearance of tumor necrosis factor-alpha and soluble TNF-receptors I and II in peritoneal effluent of CAPD

1 reference

12 December 2020

Expression of adhesion molecules and chemotactic cytokines in cultured human mesothelial cells

1 reference

12 December 2020

Immunohistochemical studies of the peritoneal membrane and infiltrating cells in normal subjects and in patients on CAPD

1 reference

12 December 2020

Peritonitis in children on continuous ambulatory peritoneal dialysis

1 reference

12 December 2020

Human peritoneal mesothelial cells synthesize interleukin-8. Synergistic induction by interleukin-1 beta and tumor necrosis factor-alpha

1 reference

12 December 2020

Adherence of peritonitis-causing staphylococci to human peritoneal mesothelial cell monolayers

1 reference

12 December 2020

Effect of extracellular slime substance from Staphylococcus epidermidis on the human cellular immune response

1 reference

12 December 2020

Epidemiology of CAPD-Associated Peritonitis Caused by Coagulase-Negative Staphylococci: Comparison of Strains Isolated from Hands, Abdominal Tenckhoff Catheter Exit Site and Peritoneal Fluid

1 reference

12 December 2020

Functional characteristics of peritoneal macrophages of renal failure patients on peritoneal dialysis.

1 reference

12 December 2020

Vaccination for prevention of CAPD associated staphylococcal infection: results of a prospective multicentre clinical trial

1 reference

12 December 2020

Interferon-gamma levels in peritoneal dialysis effluents: relation to peritonitis

1 reference

12 December 2020

Human peritoneal mesothelial cell prostaglandin synthesis: induction of cyclooxygenase mRNA by peritoneal macrophage-derived cytokines

1 reference

12 December 2020

Monocyte/macrophage function in CAPD patients

1 reference

12 December 2020

Leukotriene release from peripheral and peritoneal leukocytes following exposure to peritoneal dialysis solutions

1 reference

12 December 2020

Stimulation of mesothelial cells proliferation by endogenous growth factor(s)

1 reference

12 December 2020

In vitro function of peripheral blood and peritoneal B lymphocytes from CAPD patients

1 reference

12 December 2020

Analysis of the peritoneal cellular immune system during CAPD shortly before a clinical peritonitis

1 reference

12 December 2020

Cytokine networks in continuous ambulatory peritoneal dialysis: interactions of resident cells during inflammation in the peritoneal cavity

1 reference

12 December 2020

Carrier-status for nasal staphylococci does not predict infections in CAPD patients

1 reference

12 December 2020

Plasma and dialysate immunoglobulin G in continuous ambulatory peritoneal dialysis patients: a multicenter study

1 reference

12 December 2020

Peritoneal host defense mechanisms in peritoneal dialysis

1 reference

12 December 2020

Staphylococcus aureus peritonitis is associated with Staphylococcus aureus nasal carriage in peritoneal dialysis patients

1 reference

12 December 2020

Culture-negative CAPD peritonitis: the Network 9 Study

1 reference

12 December 2020

Peritoneal macrophages and opsonins: antibacterial defense in patients undergoing chronic peritoneal dialysis

1 reference

12 December 2020

Serial changes of interleukin-6 and interleukin-8 levels in drain dialysate of uremic patients with continuous ambulatory peritoneal dialysis during peritonitis

1 reference

12 December 2020

Mesothelial hyperplasia in response to peritoneal dialysis fluid: a morphometric study in the rat

1 reference

12 December 2020

An autopsy study of the peritoneal cavity from patients on continuous ambulatory peritoneal dialysis

1 reference

12 December 2020

Lectin-mediated, nonopsonic phagocytosis of type 1 Escherichia coli by human peritoneal macrophages of uremic patients treated by peritoneal dialysis.

1 reference

12 December 2020

Pseudomonal and candidal peritonitis as a complication of continuous ambulatory peritoneal dialysis in human immunodeficiency virus-infected patients

1 reference

12 December 2020

Effect of peritoneal dialysis fluids on leukocyte function

1 reference

12 December 2020

Impact of peritoneal dialysis solutions on peritoneal immune defense

1 reference

12 December 2020

Host defense mechanisms in the peritoneal cavity of continuous ambulatory peritoneal dialysis patients. 1.

1 reference

12 December 2020

Propionibacteria isolates and asymptomatic infections of the peritoneal effluent in CAPD patients

1 reference

12 December 2020

Hypogammaglobulinemia in children undergoing continuous ambulatory peritoneal dialysis

1 reference

12 December 2020

Hypogammaglobulinemia in uremic infants receiving peritoneal dialysis

1 reference

12 December 2020

A comparison of four culture methods for diagnosing infection in continuous ambulatory peritoneal dialysis

1 reference

12 December 2020

Peritoneal morphology in children treated by continuous ambulatory peritoneal dialysis

1 reference

12 December 2020

Peritoneal dialysis fluid inhibition of phagocyte function: effects of osmolality and glucose concentration

1 reference

12 December 2020

Comparison of peritonitis rates in children on CAPD with spike connector versus two disconnect systems.

1 reference

12 December 2020

The effect of dialysate on peritoneal phagocyte oxidative metabolism

1 reference

12 December 2020

IgG2 deficiency in young children treated with continuous ambulatory peritoneal dialysis (CAPD)

1 reference

12 December 2020

Effect of the dialysate on polymorphonuclear leucocytes function in CAPD

1 reference

12 December 2020

Can the risk of peritonitis be predicted for new continuous ambulatory peritoneal dialysis (CAPD) patients?

1 reference

12 December 2020

In vivo exposure to the currently available peritoneal dialysis fluids decreases the function of peritoneal macrophages in CAPD

1 reference

12 December 2020

Macrophages and translymphatic absorption represent the first line of host defense of the peritoneal cavity

1 reference

12 December 2020

Local serum application: restoration of sufficient host defense in human peritonitis

1 reference

12 December 2020

Role of resident macrophages, peripheral neutrophils, and translymphatic absorption in bacterial clearance from the peritoneal cavity

1 reference

12 December 2020

Serological response to coagulase-negative staphylococci in patients with peritonitis on continuous ambulatory peritoneal dialysis

1 reference

12 December 2020

Peritoneal eosinophilia in patients on continuous ambulatory peritoneal dialysis: a prospective study

1 reference

12 December 2020

Microbiologic aspects of chronic ambulatory peritoneal dialysis

1 reference

12 December 2020

Peritonitis in children undergoing continuous ambulatory peritoneal dialysis

1 reference

12 December 2020

Prospective controlled trial of a Y-connector and disinfectant to prevent peritonitis in continuous ambulatory peritoneal dialysis

1 reference

12 December 2020

Phenotypic characterization of monocytes and macrophages from CAPD patients

1 reference

12 December 2020

Eicosanoid synthesis in human peritoneal macrophages stimulated with S. epidermidis

1 reference

12 December 2020

Reduced secretion of IL-1 beta by peritoneal cells from patients on continuous ambulatory peritoneal dialysis

1 reference

12 December 2020

Immunoglobulin and complement

1 reference

12 December 2020

Characteristics of peripheral and peritoneal lymphocytes from continuous ambulatory peritoneal dialysis patients

1 reference

12 December 2020

Peritonitis in continuous ambulatory peritoneal dialysis (CAPD): a multi-centre randomized clinical trial comparing the Y connector disinfectant system to standard systems. Canadian CAPD Clinical Trials Group

1 reference

12 December 2020

Lympho-monokine disorders in continuous ambulatory peritoneal dialysis

1 reference

12 December 2020

Fibronectin binding to protein A-containing staphylococci

1 reference

12 December 2020

Complement activation during CAPD.

1 reference

12 December 2020

Peritoneal defence mechanisms and Staphylococcus aureus in patients treated with continuous ambulatory peritoneal dialysis (CAPD).

1 reference

12 December 2020

Interleukin-8 during peritonitis in patients treated with CAPD; an in-vivo model of acute inflammation

1 reference

12 December 2020

Periodic elevation of complement activation products in peritoneal dialysis effluent

1 reference

12 December 2020

Antimicrobial activities of dialysate-elicited and resident human peritoneal macrophages

1 reference

12 December 2020

Short dwell times reduce the local defence mechanism of chronic peritoneal dialysis patients

1 reference

12 December 2020

Organisms causing peritonitis

1 reference

12 December 2020

The prevention of infection with Staphylococcus aureus in continuous ambulatory peritoneal dialysis

1 reference

12 December 2020

Staphylococcus aureus nasal carriage, exit-site infection and catheter loss in patients treated with continuous ambulatory peritoneal dialysis (CAPD).

1 reference

12 December 2020

Rifampin use in peritoneal dialysis

1 reference

12 December 2020

Peritonitis in peritoneal dialysis: bacterial colonization by biofilm spread along the catheter surface

1 reference

12 December 2020

Catheter-associated biofilm

1 reference

12 December 2020

Release of hydrogen peroxide and expression of HLA-DR and transferrin receptors by monocytes and peritoneal macrophages from patients undergoing continuous ambulatory peritoneal dialysis and normal controls

1 reference

12 December 2020

Moncrief-Popovich catheter: implantation technique and clinical results

1 reference

12 December 2020

Cytotoxic effects of commercial continuous ambulatory peritoneal dialysis (CAPD) fluids and of bacterial exoproducts on human mesothelial cells in vitro

1 reference

12 December 2020

1,25-Dihydroxycholecalciferol and Peritoneal Macrophage Chemotaxis in Patients on Continuous Ambulatory Peritoneal Dialysis

1 reference

12 December 2020

The interaction of organism, phagocyte and mesothelial cell

1 reference

12 December 2020

Staphylococcus aureus nasal carriage and infection in patients on continuous ambulatory peritoneal dialysis

1 reference

12 December 2020

Role of the peritoneal membrane in the control of inflammation in the peritoneal cavity

1 reference

12 December 2020

Peritoneal lymphocyte populations in CAPD patients.

1 reference

12 December 2020

Toxicity of peritoneal dialysis fluids on cultured fibroblasts, L-929.

1 reference

12 December 2020

Modulation of peritoneal macrophage antimicrobial activity by peritoneal dialysis fluid, Ca++, and 1,25(OH)2D3 in CAPD patients

1 reference

12 December 2020

Longitudinal study of proteins in plasma and dialysate during continuous ambulatory peritoneal dialysis (CAPD)

1 reference

12 December 2020

Exit-site infection in CAPD: a review

1 reference

12 December 2020

Examination of the morphology of bacteria adhering to peritoneal dialysis catheters by scanning and transmission electron microscopy

1 reference

12 December 2020

Analysis of cellular populations in peritoneal effluents of children on CAPD

1 reference

12 December 2020

Immune status of children on continuous ambulatory peritoneal dialysis

1 reference

12 December 2020

Effects of the composition of peritoneal dialysis fluid on chemiluminescence, phagocytosis, and bactericidal activity in vitro.

1 reference

12 December 2020

Host defense mechanisms in the peritoneal cavity of continuous ambulatory peritoneal dialysis patients. 2. Humoral defenses

1 reference

12 December 2020

Intraleukocytic sequestration as a cause of persistent Staphylococcus aureus peritonitis in continuous ambulatory peritoneal dialysis

1 reference

12 December 2020

Peritoneal drainage: an important element in host defence against staphylococcal peritonitis in patients on CAPD

1 reference

12 December 2020

CAPD-associated peritonitis: an immunological perspective on causes and interventions

1 reference

12 December 2020

Distinct subpopulations of elicited human macrophages in peritoneal dialysis patients and women undergoing laparoscopy: a study on peroxidatic activity.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00860966

1 reference

Dimensions Publication ID

25 September 2017

1024850463

0 references

1 reference